Cargando…
FGFR4 polymorphic alleles modulate mitochondrial respiration: A novel target for somatostatin analog action in pituitary tumors
We reported that a single nucleotide polymorphism (SNP) at codon 388 of the fibroblast growth factor receptor 4 (FGFR4-Gly388Arg) can result in distinct proteins that alter pituitary cell growth and function. Here, we examined the differential properties of the available therapeutic somatostatin ana...
Autores principales: | Ezzat, Shereen, Wang, Ri, Pintilie, Melania, Asa, Sylvia L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356897/ https://www.ncbi.nlm.nih.gov/pubmed/27966451 http://dx.doi.org/10.18632/oncotarget.13843 |
Ejemplares similares
-
The FGFR4-G388R Polymorphism Promotes Mitochondrial STAT3 Serine Phosphorylation to Facilitate Pituitary Growth Hormone Cell Tumorigenesis
por: Tateno, Toru, et al.
Publicado: (2011) -
Pituitary carcinoma: reclassification and implications in the NET schema
por: Asa, Sylvia L, et al.
Publicado: (2022) -
An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism
por: Asa, Sylvia L., et al.
Publicado: (2021) -
Clinical applications of somatostatin analogs for growth hormone-secreting pituitary adenomas
por: Wang, Ji-wen, et al.
Publicado: (2014) -
Metabolic Glucose Status and Pituitary Pathology Portend Therapeutic Outcomes in Acromegaly
por: Cheng, Sonia, et al.
Publicado: (2013)